Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.37 |
| ▸ | ADAMTS5 | Q9UNA0 | 3/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27250467 | 1.00 | LPL (0.37) | LPLLIPGADAMTS5FFAR1ADAMTS4 | |
| SCHEMBL14158883 | 0.85 | LPL (0.41) | LPLLIPGADAMTS5 | |
| SCHEMBL27250486 | 0.84 | CHRM2 (0.33) | LPLLIPGADAMTS5FFAR1ADAMTS4 | |
| SCHEMBL30124610 | 0.84 | CHRM2 (0.33) | LPLLIPGADAMTS5FFAR1ADAMTS4 | |
| SCHEMBL3758794 | 0.82 | LPL (0.40) | LPLLIPG | |
| SCHEMBL3753576 | 0.81 | LPL (0.36) | LPLLIPG | |
| SCHEMBL24719527 | 0.80 | LPL (0.40) | LPLLIPGFFAR1 | |
| SCHEMBL3758304 | 0.80 | ADAMTS5 (0.42) | LPLLIPGADAMTS5ADAMTS4 | |
| SCHEMBL14852312 | 0.79 | LPL (0.42) | LPLLIPGFFAR1 | |
| SCHEMBL3758967 | 0.79 | LPL (0.37) | LPLLIPGADAMTS5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4629986-A1 | TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | Poseidon Innovation 1, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-4629985-A1 | TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | Poseidon Innovation 1, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-4629987-A1 | TREATMENT OF MYELOPROLIFERATIVE DISEASES AND DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | Poseidon Innovation 1, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024123991-A1 | TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | POSEIDON INNOVATION 1, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024124000-A1 | TREATMENT OF MYELOPROLIFERATIVE DISEASES AND DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | POSEIDON INNOVATION 1, INC. (US) | 2024-06-13 | — | — | WO | disclosed |